And the state of the medication, whether it is an unopened pen, an opened vial, a lyophilized powder , or a reconstituted solution , dramatically changes the storage requirements
At ACR Convergence 2025, researchers from Toronto and NYU reported that PsA patients starting GLP-1 receptor agonists had significant improvements in joint counts, CRP, pain scores, and DAPSA disease activity scores within one year of treatment. Whats interesting is that you dont seem to need a large dose to see these benefits
Common applications include: Metabolic and obesity research: Studying how amylin receptor activation influences body weight, food intake, and metabolic control in preclinical and clinical research settings
But these concerns are often simply due to it being early in the dose escalation process